startup

Arden Bio is an Even One Ventures company outside cancer: it profiles the immune system of people with complex immune-mediated conditions to match them to biology-based treatments.

Echo Immune is developing personalised mRNA cancer vaccines designed from a patient's own tumour to stop cancer coming back after treatment.

Gemini Therapeutics is a startup with a single purpose: finishing the development of aldoxorubicin, a tumour-targeted form of doxorubicin, founded after the GitLab co-founder Sid Sijbrandij was treated with doxorubicin for osteosarcoma.

Ignitus Bio is an Even One Ventures company outside cancer: it aims to measure a patient's mitochondrial function and use healthy mitochondria to restore energy in failing heart and brain tissue.

Invocata is building personalised T-cell receptor therapies, choosing the right TCR for the individual patient at the right time; its site says only that it is coming soon.

Kernis Health helps cancer patients keep their own living tumour tissue after surgery, instead of letting it be discarded, so it can be used later for functional drug testing, diagnostics and trial access.

Minuteman Therapeutics develops oncolytic viruses engineered against an individual patient's tumour, matching the virus to the biology of that person's cancer.

Palitra Bio tests candidate treatments directly against a patient's own tumour cells, with a PhD data team and an MD tumour board turning the results into a personalised treatment plan.

Perita Bio is an Even One Ventures company outside cancer: precision molecular profiling of endometriosis to explore non-hormonal treatment options.

Ranata Therapeutics builds antibodies and bispecific antibodies against the unique features of an individual patient's cancer cells.

Rarivive is an Even One Ventures company outside cancer: custom gene therapies designed around a single person's mutation for rare genetic diseases.

Relit Biosciences gives patients access to biomarker-based imaging and radioligand therapy, the pairing of a diagnostic scan with a matched radioactive drug.

SciRouter is a prevention-first longevity start-up founded by Ryan Bethencourt that sells plant-based daily supplements for people, dogs and cats, and frames cancer and age-related decline as engineering problems to be prevented rather than treated.

Stitchpoint Bio is an Even One Ventures company outside cancer: antisense oligonucleotide medicines designed for a single rare disease patient's mutation, aiming to cut development from decades to months.

Valius is a patient-centred multi-omic profiling service that runs whole genome, bulk and single-cell RNA, spatial transcriptomics, high-plex protein, and ctDNA on one tumour.

Yuga Bio is an AI workspace for personalised cancer care: a patient's case wiki, agentic research on their tumour and their care team in one place, from diagnosis to treatment options.